Platform Technology Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Platform Technology Partners's BIIB Position: Q2 2026 in Review
Platform Technology Partners reduced its Biogen (BIIB) stake by 5.4% in Q2 2026, selling an estimated $12.4K and leaving 1,136 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #313.
Platform Technology Partners first reported a position in BIIB in Q4 2019 and has held it in 20 quarters since. The position peaked at $515K in Q2 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Platform Technology Partners held 1,136 shares of Biogen worth $245K as of Q2 2026.
- Platform Technology Partners sold 65 Biogen shares in Q2 2026, an estimated $12.4K.
- Biogen made up 0.04% of Platform Technology Partners's portfolio in Q2 2026, its #313 holding.
- Platform Technology Partners first reported a position in Biogen in Q4 2019 and has held it in 20 quarters since.
- Platform Technology Partners's Biogen position peaked at $515K in Q2 2021.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.